Pliant Therapeutics
PLRX
77 hedge funds and large institutions have $512M invested in Pliant Therapeutics in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 11 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 18
0.98% less ownership
Funds ownership: 85.51% → 84.53% (-0.98%)
5% less funds holding
Funds holding: 81 → 77 (-4)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
43% less capital invested
Capital invested by funds: $893M → $512M (-$381M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $812K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.12M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.76M |
| 3 |
Morgan Stanley
New York
|
+$2.49M |
| 4 |
CA
CHI Advisors
New York
|
+$2.48M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Walleye Capital
New York
| $484 | +$609K | +28,685 | New |
|
|
FCM
77
Farallon Capital Management
San Francisco,
California
| – | -$14.3M | -490,000 | Closed |
|
78
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$6.13M | -210,678 | Closed |
|
|
SFM
79
Sphera Funds Management
Tel Aviv,
Israel
| – | -$1.49M | -51,000 | Closed |
|
|
ECM
80
ExodusPoint Capital Management
New York
| – | -$422K | -14,499 | Closed |
|
81
TD Asset Management
Toronto,
Ontario, Canada
| – | -$292K | -14,442 | Closed |
|
|
BFM
82
Boothbay Fund Management
New York
| – | -$396K | -13,585 | Closed |
|
83
VOYA Investment Management
Atlanta,
Georgia
| – | -$288K | -9,905 | Closed |
|
|
CS
84
Credit Suisse
Zurich,
Switzerland
| – | -$216K | -7,464 | Closed |
|
85
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$41 | -1,400 | Closed |
|
86
Osaic Holdings
Scottsdale,
Arizona
| – | -$4K | -150 | Closed |
|
87
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -76 | Closed |
|
PLRX Hedge Fund Activity: Q3 2021 in Review
77 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q3 2021, worth a combined $512M — down 43% from $893M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of PLRX and 7 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 30 added.
The largest buyer was Vanguard Group, adding an estimated $3.12M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $14.3M sold.
- 77 institutional investors held Pliant Therapeutics (PLRX) as of Q3 2021, down from 81 in Q2 2021.
- Funds reported $512M of Pliant Therapeutics stock for Q3 2021, down 43% quarter-over-quarter.
- 7 funds opened new Pliant Therapeutics positions in Q3 2021 and 11 closed out, a net change of -4 holders.
- The largest Pliant Therapeutics buyer in Q3 2021 was Vanguard Group, an estimated $3.12M added.
- The largest Pliant Therapeutics seller in Q3 2021 was Farallon Capital Management, an estimated $14.3M sold.
Based on aggregated 13F filings for Q3 2021.